ALEXIS JONES: Open Payments
NPI 1053076232 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 99 payments from 17 companies in 2025. Trend: 2023 $837 · 2024 $1,409 · 2025 $1,718
Food & beverage: $1,656Education: $62
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $397 |
| Madrigal Pharmaceuticals | 7 | $218 |
| Aimmune Therapeutics, Inc. | 24 | $151 |
| Intercept Pharmaceuticals, Inc. | 7 | $149 |
| GENZYME CORPORATION | 4 | $113 |
| QOL Medical, LLC | 4 | $100 |
| Janssen Biotech, Inc. | 6 | $96 |
| PFIZER INC. | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Ardelyx, Inc. | 3 | $55 |
Products named: REZDIFFRA, DUPIXENT, SKYRIZI, RINVOQ, OCALIVA, ZENPEP, Sucraid, TREMFYA.
Industry payments across SC — which companies pay providers there.
